Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × PROMs × cemiplimab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Carcinoma, Renal Cell 5 Skin Neoplasms 4 Ovarian Neoplasms 4 Adenocarcinoma 4 Triple Negative Breast Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma 3 Breast Neoplasms 3 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Large Cell 2 Adrenocortical Carcinoma 2

Interventions

cemiplimab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07061379 2025-09-03

PROMOTING

IRCCS San Raffaele

PROMs

Data powered by HemOnc (CC BY 4.0) Colophon ⚡